Par Drugs and Chemicals Limited — Board Meeting, 13-11-2025: Outcome of Board Meeting
13-11-2025 | 04:43 pm
13-11-2025 | 04:43 pm
Par Drugs' board approved its Q2 and half-year financial results. The company posted Q2 revenue of ₹28.66 Cr and profit of ₹4.13 Cr. Half-year profit reached ₹7.46 Cr. Investor grievances and corporate governance reports were also reviewed.
No comments yet. Be the first to comment!
